Security Snapshot

ATI PHYSICAL THERAPY INC - COM CL A (ATIP) Institutional Ownership

CUSIP: 00216W109

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ATIP - ATI PHYSICAL THERAPY INC - COM CL A is tracked under CUSIP 00216W109.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1 to 0 between Q2 2023 and Q3 2023.
  • SEC-reported value moved from $2,366,190 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

00216W109

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Latest
n/a
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$2,375,365 0
2023 Q2 258,600 $2,366,190 -$155,124,506 $9.15 1
2023 Q1 168,845,057 $42,478,244 -$895,295 $0.25 71
2022 Q4 171,941,823 $53,043,901 -$2,097,401 $0.30 80
2022 Q3 178,370,545 $178,445,393 -$2,786,659 $1.00 93
2022 Q2 177,349,638 $250,068,494 +$4,081,392 $1.41 89
2022 Q1 173,877,012 $325,852,000 -$8,615,717 $1.88 77
2021 Q4 174,364,644 $591,048,518 -$10,271,667 $3.39 83
2021 Q3 175,892,201 $668,393,553 -$77,917,155 $3.80 77
2021 Q2 170,262,393 $1,621,878,227 +$1,618,005,227 $9.54 99
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .